Mario Strazzabosco, MD, PhD, was appointed Director and Clinical Program Leader of the Smilow Liver Cancer Program on January 1, 2017. With expertise in advanced hepatology, Dr. Strazzabosco is an expert in the care of patients with liver cancer. Dr. Strazzabosco returned to Yale after serving as the Founding Chief of the Section of Digestive Diseases, Chair of the Department of Surgery and Translational Medicine, and Vice President of the School of Medicine at the University of Milan. He is internationally known for his work in Hepatology and Liver Transplantation, previously served as Medical Director of Hepatology at Yale, is a recipient of NIH funding, and is a member of several scientific societies in Europe and in the United States. Dr. Strazzabosco holds an appointment as Professor of Medicine (Digestive Diseases) at Yale School of Medicine and as Co-Director of the Yale Liver Center. As leader of the Liver Cancer Program at Smilow Cancer Hospital, Dr. Strazzabosco will coordinate the efforts of the team to further develop the program in collaboration with the specialties of Medical Oncology, Interventional Radiology, Surgical Oncology, Hepatology, and Transplantation Surgery.